Health Care & Life Sciences » Biotechnology | Protalix BioTherapeutics Inc.

Protalix BioTherapeutics Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
27,790.00
29,943.00
27,282.00
29,176.00
85,276.00
26,457
Depreciation, Depletion & Amortization
3,539.00
3,140.00
2,370.00
1,983.00
1,920.00
1,671
Other Funds
4,094.00
3,247.00
3,932.00
6,022.00
44,259.00
3,519
Funds from Operations
20,157.00
23,556.00
20,980.00
33,215.00
39,097.00
21,267
Changes in Working Capital
10,496.00
5,725.00
3,304.00
1,117.00
29,103.00
13,525
Net Operating Cash Flow
30,653.00
29,281.00
24,284.00
32,098.00
9,994.00
7,742
Capital Expenditures
1,890.00
785.00
464.00
849.00
971.00
Sale of Fixed Assets & Businesses
-
11.00
3.00
20.00
3.00
Net Investing Cash Flow
2,102.00
1,001.00
39,342.00
861.00
973.00
Issuance/Reduction of Debt, Net
66,780.00
-
-
19,681.00
1,419.00
Net Financing Cash Flow
66,892.00
46.00
6,635.00
19,695.00
1,419.00
Net Change in Cash
34,363.00
31,631.00
21,562.00
12,987.00
11,972.00
Free Cash Flow
32,543.00
30,066.00
24,748.00
32,947.00
10,965.00
Other Sources
-
-
39,899.00
-
-
Change in Capital Stock
112.00
46.00
6,635.00
14.00
-
Exchange Rate Effect
226.00
1,395.00
131.00
277.00
414.00
Other Uses
212.00
227.00
96.00
32.00
5.00

About Protalix BioTherapeutics

View Profile
Address
2 Snunit Street
Carmiel HZ 21614
Israel
Employees -
Website http://www.protalix.com
Updated 07/08/2019
Protalix Biotherapeutics, Inc. engages in the development and commercialization of recombinant therapeutic proteins based on ProCellEx plant cell based expression system. It offers Taliglucerase alfa injections under the brand name Elelyso, an enzyme replacement therapy for Gaucher disease. The company's drugs also include Oral Glucocerebrosidase for potential treatment of Gaucher disease; therapeutic proteins for Fabry disease, and immune diseases such as rheumatoid, psoriatic and juvenile idiopathic arthritis, ankylosing, spondylitis, and plaque psoriasis; and protein for biodefense and other indications.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.